News

Manel Esteller bestowed with the European Association for Cancer Research (EACR) Award Lecture

The Director of the Cancer Epigenetics and Biology program of IDIBELL, Manel Esteller has been awarded the 2011 European Association for Cancer Research (EACR) Cancer Researcher Award Lecture.

Leer más about Manel Esteller bestowed with the European Association for Cancer Research (EACR) Award Lecture

The Spanish Health Research Fund will finance 27 IDIBELL research projects

The Instituto de Salud Carlos III has issued a preliminary determination of the grant program in Health Research Projects of the Health Research Fund (FIS), corresponding to the call of 2011. The 27 IDIBELL selected projects will receive three million 400 000 Euros over the next four years.

Leer más about The Spanish Health Research Fund will finance 27 IDIBELL research projects

International experts participate in the Genomic Imprinting Conference, organized by IDIBELL

The “Imprinting and Beyond: Monoallelic expression in Health and Disease” conference, hosted by David Monk (PEBC-IDIBELL) and Robert Feil (CNRS-Montpellier, France) was held on the 21st-23rd September at Institut d’Estudis Catalans. Institut d’Estudis Catalans

Leer más about International experts participate in the Genomic Imprinting Conference, organized by IDIBELL

Manel Esteller receives the National Genetics Award

The awarded scientifics are the IDIBELL researcher, Manel Esteller, and the professor of genetics at the University of Seville, Enrique Cerdà, in the categories of applications to genetics and basic genetics, respectively.

Leer más about Manel Esteller receives the National Genetics Award

Andrew Plested: “We want to know how neurons obtain information, how they store it and how they process it

In order to answer these ambitious questions, Andrew Plestan focuses his research on one of the pieces involved in these processes: the glutamate receptors. “By understanding how they work, we understand the neural connections and how the brain processes and stores information.” Plested has explained his progress in a session within the IDIBELL seminar series on  September 16th.

Leer más about Andrew Plested: “We want to know how neurons obtain information, how they store it and how they process it

IDIBELL brings together outstanding experts on Bioinformatics, Systems Biology and Regulatory Genomics

Outstanding experts in bioinformatics, systems biology and regulatory genomics from around the world will meet from 14 to 19 October at IDIBELL to discuss the latest developments in these fields. DREAM ENGINEERING CHALLENGES President: Gustavo Stolovitzky CANCER CONFERENCE ON RICCI Informatics President: Miguel Angel Pujana RECOMB Systems Biology President: Andrea Califano RECOMB REGULATORY GENOMICS President: Manolis Kells

Leer más about IDIBELL brings together outstanding experts on Bioinformatics, Systems Biology and Regulatory Genomics

IDIBELL researchers discover a potential treatment against an aggressive childhood cancer

A molecule very similar to glucose kills ‘in vitro’ tumor cells of alveolar rhabdomyosarcoma New therapeutic strategies Article’s reference

Leer más about IDIBELL researchers discover a potential treatment against an aggressive childhood cancer

The course begins at IDIBELL

The new course begins in IDIBELL with the resumption of external seminars. As always, the sessions take place on Friday at one pm in the auditorium of the Duran Reynals Hospital (ICO), the Bellvitge University Hospital and the Bellvitge Campus of the University of Barcelona. More information

Leer más about The course begins at IDIBELL

IUD reduces by half the risk of cervical cancer

The study involved more than 20 000 women from different countries Intrauterine devices (IUDs) may protect against cervical cancer. This is the conclusion of the broadest epidemiological study to date in which has participated the research group in Viruses and Cancer of IDIBELL, published at The Lancet Oncology. Reduces  the risk by half Article’s reference

Leer más about IUD reduces by half the risk of cervical cancer
Scroll to Top